Name of Company: Acutus Medical Inc.
Industry: Medical devices
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Location: San Diego, California and Zurich, Switzerland
Solution/Product: An electrophysiology diagnostic product to map cardiac arrhythmias.
Money Raised: $2.5 million out of a $5 million in an expanded Series A roundh. The company raised $5.4 million in January.
How it will be used: To support ongoing technology development, said the company’s CEO.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Investors: Index Ventures, Advent Venture Partners
Management team: Randy Werneth, Founder, President & CEO; Graydon Beatty, Chief Technology Officer; Tim Corvi, President of Research and Development
Market: Large companies like Boston Scientific makes diagnostic catheters to map the heart’s electrical signals. And then there is iRhythm Technologies, a startup that makes a wearable patch that can monitor and diagnose cardiac arrhythmia. There are several million Americans estimated to have undiagnosed cardiac arrythmias.
[Photo Credit: freedigitalphotos user Salvatore Vuono]
